Come up with a name for your new list and we'll add to it:
Metamark Genetics raised a round of funding on February 17, 2012. Investors include
Massachusetts Life Sciences Center.
Metamark Genetics is a privately-held biotechnology company founded to develop novel, function-based prognostic and diagnostic tests aimed at improving urological cancer care. Metamark is a provider o…